Variant report
Variant | esv3399250 |
---|---|
Chromosome Location | chr8:35418810-35422308 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373574245 | chr8:35418825-35418826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542901249 | chr8:35418895-35418896 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182371580 | chr8:35418903-35418904 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73674023 | chr8:35418929-35418930 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs188019283 | chr8:35418949-35418950 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576805846 | chr8:35419038-35419039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs59776488 | chr8:35419045-35419046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140887778 | chr8:35419090-35419091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116714890 | chr8:35419135-35419136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192586076 | chr8:35419211-35419212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs35972407 | chr8:35419235-35419236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184466521 | chr8:35419275-35419276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74955707 | chr8:35419278-35419279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2589760 | chr8:35419308-35419309 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs527632157 | chr8:35419342-35419343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs56276341 | chr8:35419362-35419363 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs115453469 | chr8:35419386-35419387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367623899 | chr8:35419387-35419388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144833972 | chr8:35419408-35419409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150892538 | chr8:35419415-35419416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7832996 | chr8:35419451-35419452 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs7833005 | chr8:35419465-35419466 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs553388977 | chr8:35419484-35419485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571702121 | chr8:35419587-35419588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572287426 | chr8:35419589-35419590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139409171 | chr8:35419596-35419597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554850381 | chr8:35419608-35419609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188996238 | chr8:35419649-35419650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544015666 | chr8:35419653-35419654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565314636 | chr8:35419678-35419679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150072304 | chr8:35419742-35419743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541534801 | chr8:35419760-35419761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559839659 | chr8:35419776-35419777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546073355 | chr8:35419809-35419810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564107179 | chr8:35419810-35419811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375937913 | chr8:35419816-35419817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7834535 | chr8:35419824-35419825 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs550362956 | chr8:35419945-35419946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531487012 | chr8:35419962-35419963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192664443 | chr8:35419964-35419965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7821725 | chr8:35420001-35420002 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs184529996 | chr8:35420002-35420003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547091644 | chr8:35420059-35420060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188893262 | chr8:35420174-35420175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531345209 | chr8:35420244-35420245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115744588 | chr8:35420248-35420249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570354716 | chr8:35420268-35420269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145181674 | chr8:35420300-35420301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559152883 | chr8:35420324-35420325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs548541561 | chr8:35420342-35420343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 21806811 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bladder cancer | 19088036 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 20459607 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Neuroticism | 17667963 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 17001308 | CNVD |
Breast cancer | 17157792 | CNVD |
Cancer | 17001308 | CNVD |
Cancer | 18840272 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Breast cancer | 21328542 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Intellectual disability | 22045946 | CNVD |
Lung cancer | 17925434 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21364760 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:35414800-35424200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr8:35415000-35423400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr8:35415000-35431000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr8:35416000-35419200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr8:35416200-35419000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr8:35416400-35419000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr8:35417800-35419200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr8:35418000-35419000 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr8:35418000-35419000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr8:35418200-35419000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr8:35418200-35419000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr8:35418200-35419000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr8:35418200-35419000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr8:35418400-35419000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
15 | chr8:35418400-35419000 | Enhancers | H9 Cell Line | embryonic stem cell |
16 | chr8:35418800-35423000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
17 | chr8:35418800-35423200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
18 | chr8:35419000-35421600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr8:35419000-35423200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
20 | chr8:35419000-35423400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
21 | chr8:35419000-35430200 | Weak transcription | H9 Cell Line | embryonic stem cell |
22 | chr8:35419000-35439400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
23 | chr8:35419000-35439600 | Weak transcription | H1 Cell Line | embryonic stem cell |
24 | chr8:35419200-35423000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
25 | chr8:35419200-35427600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
26 | chr8:35421800-35422000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |